https://www.selleckchem.com/pr....oducts/ZM-447439.htm
The authors declare they have no actual or potential competing financial interests. N/A. N/A. Artificial intelligence (AI) is increasingly being proposed for use in medicine, including breast cancer screening (BCS). Little is known, however, about referring primary care providers' (PCPs' preferences for this technology. We identified the most important attributes of AI BCS for ordering PCPs using qualitative interviews sensitivity, specificity, radiologist involvement, understandability of AI decision-making, supporting evidence, and